Anti-C3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases
US12344663B2 · kind B2 · utility
0Cited by
21References
94Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 21, 2022 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Dec 21, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4716
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies and fragments thereof that target the complement C3. More specifically, anti-C3 antibodies and methods of use for the treatment of various diseases or disorders are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.